Cadila Healthcare Limited vs Cadila Pharmaceuticals Limited on 26 March, 2001
In Cadila Health Care Ltd. v. Cadila
Pharmaceuticals Limited (2001) 5 SCC 73, the Hon'ble Supreme Court
concluded that the risk of confusion and deception on the part of the
public should be accorded highest importance in the context of
pharmaceutical products.